TREATMENT OF SYSTEMIC IMMUNE ACTIVATION SYNDROMES

摘要

The disclosure provides methods of treating a patient who has, or who is at risk for developing, systemic immune activation, includeing cytokine release syndrome (CRS) and sepsis. The method comprises administering a therapeutically effective amount of a compound of Formula (I) the patient.